Conference
A prospective study to evaluate the role of 2-[ 18 f] fluoro-2-deoxy-d-glucose (FDG)-positron emission tomography (PET), breast magnetic resonance imaging (MRI), and breast ultrasonography in monitoring tumor responses in patients with locally advanced breast cancer (LABC) undergoing neoadjuvant chemotherapy.
Authors
Mukherjee SD; Dhamanaskar K; Tozer R; Hodgson N; MacGillivray M; Gu C; Cline K; Elavathil L; Julian J; Gulenchyn KY
Volume
28
Pagination
pp. 595-595
Publisher
American Society of Clinical Oncology (ASCO)
Publication Date
May 20, 2010
DOI
10.1200/jco.2010.28.15_suppl.595
Conference proceedings
Journal of Clinical Oncology
Issue
15_suppl
ISSN
0732-183X